Clover Biopharmaceuticals, a Chinese pre-revenue drug developer that has raised $315 million across several funding rounds since 2011, has filed for a Hong Kong IPO.
The company claims to be a leading COVID-19 vaccine developer and potentially one of the first companies to commercialize a protein-based COVID-19 vaccine globally. Its vaccine candidate can survive at...
Black Sesame Technologies, a China-based chipmaker specializing in autonomous driving applications, has raised several hundred million dollars through two funding rounds at a valuation of $2 billion.
Nreal, a Chinese manufacturer of advanced artificial reality (AR) glasses that resemble normal sunglasses, has raised a Series C of $100 million led by Nio Capital, Yunfeng Capital, and Hongtai Capital.
Pacific Century Group’s insurance technology business, Bolttech, has extended a recent $180 million Series A round to $210 million in total.
Australian private equity firm Liverpool Partners has acquired a majority stake in Seven Miles Coffee Roasters, a branded coffee supplier to the local cafe segment.